Cancer Researchers in History | Medulloblastoma | Diabetes, Cancer Information Highlights, 07/21/2021

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
New from NCI
Cancer Research Starts Here
NCA50 logo   We’re shining a spotlight on some of the researchers who’ve helped shape our understanding of cancer. Read their stories to learn more.
For Kids with Medulloblastoma, Trial Suggests Radiation Can Be Tailored
a CT scan of of the radiation therapy plan for child with medulloblastoma   Read about the results of a large clinical trial that suggest that some kids may safely get less radiation without limiting their long-term survival. Others may still need the standard dose.
Could a Diabetes Diagnosis Help Detect Pancreatic Cancer Early?
Infographic showing that 1 in 100 people with new-onset diabetes are diagnosed with pancreatic cancer within 3 years. And 1 in 4 people diagnosed with pancreatic cancer were first diagnosed with diabetes.   Many studies have pointed to a link between new-onset diabetes and pancreatic cancer. Now, a number of large NCI-supported studies are testing ways to pick out those people whose diabetes might be a sign of early pancreatic cancer, when treatments may be more effective.
Genetic Clues May Lead to Tailored Treatments for Rare Childhood Cancer

In children with rhabdomyosarcoma, the presence of mutations in several genes appears to be linked to a more aggressive form of the disease and a poorer chance of survival. Learn more about the international study that led to these findings.
Annual Report to the Nation: Overall Cancer Death Rates Continue to Decline

A rapid decrease in deaths from lung cancer and melanoma has led to a continued drop in the rate of deaths from all cancers in the United States. This drop was seen in men and women of all racial and ethnic groups.

PDQ Updates
Adult Non-Hodgkin Lymphoma Treatment

We’ve updated the targeted therapy section in our PDQ summary on the treatment of adult non-Hodgkin lymphoma (NHL). Treatment options were also updated for recurrent NHL and indolent, noncontiguous stage II, III, or IV NHL.
FDA Approvals
Daratumumab and Hyaluronidase-fihj

We’ve updated our drug summary on daratumumab and hyaluronidase-fihj (Darzalex Faspro) with a new Food and Drug Administration approval. The drug is now approved to be used together with pomalidomide and dexamethasone to treat adults who have received at least one prior treatment for multiple myeloma.
Also of Interest
Alcohol and Cancer Risk

This page reviews the research linking alcohol use to the risk of various cancers. Learn about factors that affect the risk of alcohol-related cancers.
Coronavirus Vaccines and People with Cancer

Many people being treated for cancer are asking whether they should get a COVID-19 vaccine. On this page, an expert answers questions and responds to concerns about the vaccine.
Contact Us for Help

Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.